Loading...
Loading...
IceCure Medical Ltd.
IceCure Medical Ltd.. Spoken Alpha tracks ICCM's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks ICCM's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ICCM.
curl https://api.spokenalpha.com/v1/companies/ICCM| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.66 | $0.95 | -30.1% | -0.9% | -3.5% |
| Q4 FY2026 | $0.84 | $1.01 | -17.0% | -2.5% | -1.7% |
| Q3 FY2026 | $0.78 | $1.08 | -27.7% | +6.2% | +3.8% |
| Q2 FY2026 | $0.78 | $0.93 | -16.2% | -4.1% | -4.3% |
| Q1 FY2025 | $0.84 | $1.05 | -19.7% | -3.1% | -4.4% |
| Q4 FY2025 | $0.80 | $1.12 | -28.2% | +4.7% | +3.7% |
| Q3 FY2025 | $0.75 | $0.95 | -21.0% | +2.1% | +2.4% |
| Q2 FY2025 | $0.89 | $1.10 | -19.1% | -2.2% | -2.8% |
| Q1 FY2024 | $0.96 | $1.21 | -20.9% | -1.1% | -3.2% |
| Q4 FY2024 | $0.95 | $1.16 | -18.0% | -0.7% | -0.1% |